Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis
Summary: Amyotrophic lateral sclerosis (ALS) has been genetically linked to mutations in RNA-binding proteins (RBPs), including FUS. Here, we report the RNA interactome of wild-type and mutant FUS in human motor neurons (MNs). This analysis identified a number of RNA targets. Whereas the wild-type p...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124719307247 |
id |
doaj-a0559fea2e6b40cd87a2cbd26af3afa5 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Riccardo De Santis Vincenzo Alfano Valeria de Turris Alessio Colantoni Laura Santini Maria Giovanna Garone Giuseppe Antonacci Giovanna Peruzzi Emma Sudria-Lopez Emanuel Wyler Jasper J. Anink Eleonora Aronica Markus Landthaler R. Jeroen Pasterkamp Irene Bozzoni Alessandro Rosa |
spellingShingle |
Riccardo De Santis Vincenzo Alfano Valeria de Turris Alessio Colantoni Laura Santini Maria Giovanna Garone Giuseppe Antonacci Giovanna Peruzzi Emma Sudria-Lopez Emanuel Wyler Jasper J. Anink Eleonora Aronica Markus Landthaler R. Jeroen Pasterkamp Irene Bozzoni Alessandro Rosa Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis Cell Reports |
author_facet |
Riccardo De Santis Vincenzo Alfano Valeria de Turris Alessio Colantoni Laura Santini Maria Giovanna Garone Giuseppe Antonacci Giovanna Peruzzi Emma Sudria-Lopez Emanuel Wyler Jasper J. Anink Eleonora Aronica Markus Landthaler R. Jeroen Pasterkamp Irene Bozzoni Alessandro Rosa |
author_sort |
Riccardo De Santis |
title |
Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis |
title_short |
Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis |
title_full |
Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis |
title_fullStr |
Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis |
title_full_unstemmed |
Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis |
title_sort |
mutant fus and elavl4 (hud) aberrant crosstalk in amyotrophic lateral sclerosis |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2019-06-01 |
description |
Summary: Amyotrophic lateral sclerosis (ALS) has been genetically linked to mutations in RNA-binding proteins (RBPs), including FUS. Here, we report the RNA interactome of wild-type and mutant FUS in human motor neurons (MNs). This analysis identified a number of RNA targets. Whereas the wild-type protein preferentially binds introns, the ALS mutation causes a shift toward 3′ UTRs. Neural ELAV-like RBPs are among mutant FUS targets. As a result, ELAVL4 protein levels are increased in mutant MNs. ELAVL4 and mutant FUS interact and co-localize in cytoplasmic speckles with altered biomechanical properties. Upon oxidative stress, ELAVL4 and mutant FUS are engaged in stress granules. In the spinal cord of FUS ALS patients, ELAVL4 represents a neural-specific component of FUS-positive cytoplasmic aggregates, whereas in sporadic patients it co-localizes with phosphorylated TDP-43-positive inclusions. We propose that pathological mutations in FUS trigger an aberrant crosstalk with ELAVL4 with implications for ALS. : De Santis et al. show that the mutant RNA-binding protein FUS, linked to amyotrophic lateral sclerosis (ALS), targets other RNA-binding proteins, such as ELAVL4, in human motor neurons. This triggers aberrant crosstalk between mutant FUS and ELAVL4, which is found in pathological inclusions of ALS patients’ motor neurons. Keywords: FUS, ELAVL4, HuD, amytrophic lateral sclerosis, motor neuron, PAR-CLIP, TDP-43, stress granules, RNA-binding protein, Brillouin |
url |
http://www.sciencedirect.com/science/article/pii/S2211124719307247 |
work_keys_str_mv |
AT riccardodesantis mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT vincenzoalfano mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT valeriadeturris mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT alessiocolantoni mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT laurasantini mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT mariagiovannagarone mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT giuseppeantonacci mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT giovannaperuzzi mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT emmasudrialopez mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT emanuelwyler mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT jasperjanink mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT eleonoraaronica mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT markuslandthaler mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT rjeroenpasterkamp mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT irenebozzoni mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis AT alessandrorosa mutantfusandelavl4hudaberrantcrosstalkinamyotrophiclateralsclerosis |
_version_ |
1725866630995509248 |
spelling |
doaj-a0559fea2e6b40cd87a2cbd26af3afa52020-11-24T21:54:39ZengElsevierCell Reports2211-12472019-06-01271338183831.e5Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral SclerosisRiccardo De Santis0Vincenzo Alfano1Valeria de Turris2Alessio Colantoni3Laura Santini4Maria Giovanna Garone5Giuseppe Antonacci6Giovanna Peruzzi7Emma Sudria-Lopez8Emanuel Wyler9Jasper J. Anink10Eleonora Aronica11Markus Landthaler12R. Jeroen Pasterkamp13Irene Bozzoni14Alessandro Rosa15Center for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy; Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, ItalyDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, ItalyCenter for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, ItalyDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, ItalyDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, ItalyDepartment of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, ItalyCenter for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, ItalyCenter for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, ItalyDepartment of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the NetherlandsBerlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Strasse 10, 13125 Berlin, GermanyAmsterdam UMC, University of Amsterdam, Department of (Neuro)Pathology, Amsterdam Neuroscience, Meibergdreef 9, 1105 AZ Amsterdam, the NetherlandsAmsterdam UMC, University of Amsterdam, Department of (Neuro)Pathology, Amsterdam Neuroscience, Meibergdreef 9, 1105 AZ Amsterdam, the NetherlandsBerlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Robert-Rössle-Strasse 10, 13125 Berlin, Germany; IRI Life Sciences, Institute für Biologie, Humboldt Universität zu Berlin, Philippstraße 13, 10115 Berlin, GermanyDepartment of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the NetherlandsCenter for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy; Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, ItalyCenter for Life Nano Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy; Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy; Corresponding authorSummary: Amyotrophic lateral sclerosis (ALS) has been genetically linked to mutations in RNA-binding proteins (RBPs), including FUS. Here, we report the RNA interactome of wild-type and mutant FUS in human motor neurons (MNs). This analysis identified a number of RNA targets. Whereas the wild-type protein preferentially binds introns, the ALS mutation causes a shift toward 3′ UTRs. Neural ELAV-like RBPs are among mutant FUS targets. As a result, ELAVL4 protein levels are increased in mutant MNs. ELAVL4 and mutant FUS interact and co-localize in cytoplasmic speckles with altered biomechanical properties. Upon oxidative stress, ELAVL4 and mutant FUS are engaged in stress granules. In the spinal cord of FUS ALS patients, ELAVL4 represents a neural-specific component of FUS-positive cytoplasmic aggregates, whereas in sporadic patients it co-localizes with phosphorylated TDP-43-positive inclusions. We propose that pathological mutations in FUS trigger an aberrant crosstalk with ELAVL4 with implications for ALS. : De Santis et al. show that the mutant RNA-binding protein FUS, linked to amyotrophic lateral sclerosis (ALS), targets other RNA-binding proteins, such as ELAVL4, in human motor neurons. This triggers aberrant crosstalk between mutant FUS and ELAVL4, which is found in pathological inclusions of ALS patients’ motor neurons. Keywords: FUS, ELAVL4, HuD, amytrophic lateral sclerosis, motor neuron, PAR-CLIP, TDP-43, stress granules, RNA-binding protein, Brillouinhttp://www.sciencedirect.com/science/article/pii/S2211124719307247 |